Modulation of Warfarin Sodium into Warfarin Potassium for Patients with Hypertension

Al-Baraa Akram

Authors

Al-Baraa Akram

warfain, hypertension, international normalized ratio, therapeutic window, clinical trials, pharmaco-genomics, CYP2C9*3

Abstract

Abstract not found

Downloads

How to Cite

Modulation of Warfarin Sodium into Warfarin Potassium for Patients with Hypertension. (2022). Global Journal of Science Frontier Research, 22(G2), 1-14. https://journalofscience.org/index.php/GJSFR/article/view/102558

Download Citation

References

E Ravina (2011) The Evolution of Drug Discovery: From Traditional Medicines to Modern Drugs. 148.

Gregory Lim (2017) Warfarin: from rat poison to clinical use.

(1982) Contents. 295-300.

Natalie J Carroll, Dennis R Buckmaster, Neil A Knobloch (2011) What Motivates Agricultural Students?.

Jack Ansell, Alan Jacobson, Jonathan Levy, Heinz Völler, J Hasenkam (2005) Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. 99(1), 37-45.

J Levy, W Ageno, N Chan, M Crowther, P Verhamme, J Weitz (2016) When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. 14(3), 623-627.

O Macina, J Schardein (2007) Warfarin. 193-194.

Anne Holbrook, Sam Schulman, Daniel Witt, Per Vandvik, Jason Fish, Michael Kovacs, Peter Svensson, David Veenstra, Mark Crowther, Gordon Guyatt (2012) Evidence-Based Management of Anticoagulant Therapy. 141(2), e152S-e184S.

D Garcia, M Crowther, W Ageno (2010) Practical management of coagulopathy associated with warfarin. 340(apr19 1), c1813-c1813.

D Brown, E Wilkerson, W Love (2015) A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons. 72(3), 524-534.

A Camm, G Lip, De Caterina, R Savelieva, I Atar, D Hohnloser, S (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. 33(21), 2719-2747.

Marwa Shoeb, Margaret Fang (2013) Assessing bleeding risk in patients taking anticoagulants. 35(3), 312-319.

Meghan Elliott, Deborah Zimmerman, Rachel Holden (2007) Warfarin Anticoagulation in Hemodialysis Patients: A Systematic Review of Bleeding Rates. 50(3), 433-440.

Margaret Fang, Alan Go, Yuchiao Chang, Leila Borowsky, Niela Pomernacki, Natalia Udaltsova, Daniel Singer (2011) A New Risk Scheme to Predict Warfarin-Associated Hemorrhage. 58(4), 395-401.

Yusheng Zhu, Michael Shennan, Kristen Reynolds, Nancy Johnson, Matthew Herrnberger, Roland Valdes, Mark Linder (2007) Estimation of Warfarin Maintenance Dose Based on VKORC1 (−1639 G>A) and CYP2C9 Genotypes. 53(7), 1199-1205.

M Caldwell, R Berg, K Zhang, I Glurich, J Schmelzer, S Yale Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity.